On behalf of the ECMM board it is our pleasure to announce the release of the new ECMM website.
Please go to www.ecmm.info to be forwarded.
The Impact Factor of MYCOSES increased to 2.24, reflecting the large interest in the science published in our society’s journal and the strong international visibility. A total of 201 articles have been published in 2012/2013 and these have been cited 450 times in 2014.
The editors Oliver Cornely, Jacques Meis, and Martin Schaller sincerely thank all authors and reviewers and the entire editorial board of MYCOSES!
ECMM Educational Symposium on Ecology and Mycology: From the environment to the patient’s bed; 14-16 February 2016, Tel-Aviv, Israel
Scope: Environmental changes have been recognized to exert significant effects on infections and specifically on those caused by fungi. The implications of environmental changes are expressed in different epidemiological patterns, in changes of pathogenic flora in various clinical entities, which in turn may lead to the necessity of different therapeutic approaches.
A scholarship for the Masters in Medical Mycology Programme is available for the academic year 2015-2016.
Full details can be found on the website:
ESCMID Postgraduate Education Course: Diagnosis and Management of Fungal Infections Both in the West and the East.
For all presentations in session 1-5 see below:
New Mexico VA Health Care System and University of New Mexico are seeking an Academic Infectious Diseases Specialist, open rank. The ideal candidate is an accomplished physician¬-investigator, including NIH or VA funding, and strong productivity as demonstrated by a track record of grants and peer-reviewed publications. Research focus in any aspect of fungal pathogenesis, antifungal drug discovery, clinical investigation of IFI's, or any broad topic related to IFI's is of particular interest. Lab space and startup package will be offered to the qualified candidate.
The Fungal Infection Trust has supported individuals and teams working on fungal disease for 24 years and provided over £3.5 million in funding. It supports The Aspergillus Website and LIFE initiative. Partly to raise awareness and partly for fundraising, it was awarded a charity place in the London marathon this year. Dr Jenny Long is an ENT trainee and running for the FIT, in a stunning hat! Please support her.
Jenny’s page: http://www.fit.care/
The new website of the Société Française de Mycologie Médicale (SFMM) which is now in French and English, is online.
on http://sfmm-mycologie-medicale.com you can find all news related to the society, particularly the agenda and the journal.
On March 6, 2014 the FDA approved isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis.
Here you can find the FDA press release
While the aspergillosis indication is based on a large, well-designed randomized clinical trial, the mucormycosis indication is based single arm study results compared to literature data and a comparison with results from the ECMM FungiScope registry. For ECMM this is a unprecedented success in this area.
Oliver A. Cornely
President of the ECMM
It is a great pleasure to invite you to the Post-Graduate Training Course “Paediatric Mycology” organized by European Paediatric Mycology Network (EPMyN). The EPMyN has been launched in 2014 to create a European platform for research and education in paediatric mycology with the ultimate goal to increase our understanding of invasive fungal infections in children and neonates and to improve the outcome.